NM_001010898.4:c.175G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001010898.4(SLC6A17):c.175G>A(p.Asp59Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000732 in 1,612,768 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001010898.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A17 | ENST00000331565.5 | c.175G>A | p.Asp59Asn | missense_variant | Exon 2 of 12 | 2 | NM_001010898.4 | ENSP00000330199.3 | ||
SLC6A17-AS1 | ENST00000430098.2 | n.515C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 1 | |||||
SLC6A17-AS1 | ENST00000418579.1 | n.161C>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 | |||||
SLC6A17-AS1 | ENST00000443008.1 | n.500C>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000330 AC: 50AN: 151340Hom.: 1 Cov.: 30
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250314Hom.: 0 AF XY: 0.0000739 AC XY: 10AN XY: 135314
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461428Hom.: 0 Cov.: 33 AF XY: 0.0000619 AC XY: 45AN XY: 726980
GnomAD4 genome AF: 0.000330 AC: 50AN: 151340Hom.: 1 Cov.: 30 AF XY: 0.000338 AC XY: 25AN XY: 73868
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.175G>A (p.D59N) alteration is located in exon 2 (coding exon 1) of the SLC6A17 gene. This alteration results from a G to A substitution at nucleotide position 175, causing the aspartic acid (D) at amino acid position 59 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at